The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,766.50
Bid: 1,766.00
Ask: 1,767.00
Change: 33.00 (1.90%)
Spread: 1.00 (0.057%)
Open: 1,736.00
High: 1,766.50
Low: 1,736.00
Prev. Close: 1,733.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

GLOBAL MARKETS-World stocks firm, bonds win respite from rout

Wed, 09th Feb 2022 09:36

* Stocks rally, bond yields edge off highs

* U.S. stock futures higher

* Upbeat earnings support sentiment
(Changes dateline to London, updates throughout)

By Dhara Ranasinghe

LONDON, Feb 9 (Reuters) - World stock markets rallied on
Wednesday, putting aside worries about rising interest rates for
now to take some comfort from positive headlines coming out of
Ukraine and upbeat earnings.

The pan-European STOXX 600 climbed almost 1.5%.
That followed a strong session in Asia, where MSCI's broadest
index of Asia-Pacific shares outside Japan rose
1.5% to a two-week high and the blue-chip Nikkei closed 1.08%
higher.

U.S. stock futures pointed to a strong open for Wall Street,
where shares ended sharply higher on Tuesday.

News headlines over recent days suggesting tensions between
the West and Russia over Ukraine may be easing and a string of
upbeat earnings appeared to be lifting sentiment towards risk
assets, and a selloff in bond markets abated.

French President Emmanuel Macron, who met Russian President
Vladimir Putin on Monday, said on Tuesday he believed steps can
be taken to de-escalate the crisis in which Russia has massed
troops near Ukraine but says it does not plan an attack.

On the earnings front, French fund manager Amundi
on Wednesday posted a strong rise in earnings, quarterly results
from British drugmaker GSK beat forecasts, while Dutch
bank ABN Amro reported a higher-than-expected net
profit of 552 million euros for the fourth quarter.

"Last few days have seen positive headlines over
Russia/Ukraine with negotiations between Macron and Putin and
reports of German efforts to deescalate the crisis," said Mohit
Kumar, managing director, interest rates strategy, Jefferies.

"But we retain our view that a greater concern for risky
assets is a removal of central bank accommodation as markets
have become used to abundant liquidity and low rates for a long
period of time."

Major central banks have become more hawkish in the face of
stickier than anticipated inflation.

Barring any big surprises, Thursday's U.S. consumer price
index should cement expectations the Federal Reserve will raise
interest rates next month, with a strong print offering further
support to those tipping a larger 50 basis point rise.

Japan's 10-year government bond yield touched
0.215%, its highest since January 2016.

But after sharp sell-off, broader bond markets appeared to a
win a respite.

In early London trade, the U.S. 10-year Treasury yield was
down about 3 basis points at 1.92% but not far off
the highest levels since late 2019 hit on Tuesday.

Germany's 10-year Bund yield was 5 basis points lower on the
day at 0.21%.

Last week's hawkish stance by the European Central Bank has
left Bund yields 20 bps higher in the month so far and on track
for their biggest monthly rise in a year.

Rising borrowing costs and signs of rates normalisation in
Europe have boosted bank stocks -- a sub-index of European
banking stocks is at its highest since July 2018, up
almost 4% since last Thursday's ECB meeting.

Manishi Raychaudhuri, Asia-Pacific equity strategist at BNP
Paribas, said market volatility was lingering as investors tried
to figure out how often, how far and how fast central banks
would raise interest rates.

"The overarching theme for the market is central banks’
monetary policies," he said. "I think volatilities will continue
and will possibly increase ... but over the longer term
corporate balance sheets, particularly in Asian emerging markets
look a lot better than they were earlier."

Currency markets were relatively quiet, with the dollar
index, which measures the greenback against six peers,
little changed at 95.556.

Oil prices were slightly higher, recovering some ground from
a sharp drop on Tuesday when concerns of a possible rise in
supplies from Iran weighed on the market.

Brent crude futures rose 0.2%, to $90.97 a barrel,
while U.S. crude was at $89.52 a barrel, up 0.2%.

Spot gold was steady at $1,826.5 per ounce.

(Reporting by Dhara Ranasinghe; Additional reporting by Xie Yu
and Alun John in HONG KONG; Editing by Timothy Heritage)

More News
Today 09:51

LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Friday:

Read more
2 May 2024 19:57

GSK knew about Zantac cancer risk, attorneys tell jury in first trial

May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer Ingelheim knew the product could cause cancer if it was not handled properly but failed to warn the public.

Read more
2 May 2024 09:48

LONDON BROKER RATINGS: Deutsche Bank likes TP ICAP but says sell CMC

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 May 2024 19:39

Bird flu testing shows more dairy products are safe, US FDA says

CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration said on Wednesday.

Read more
1 May 2024 17:31

UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh

FTSE 100 down 0.3%, FTSE 250 off 0.2%

*

Read more
1 May 2024 16:56

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.

Read more
1 May 2024 16:42

London close: Stocks fall ahead of US Fed decision

(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.

Read more
1 May 2024 11:55

LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage

(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.

Read more
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 22:39

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.